Search

27 Feb 2018: This move would lead to him becoming a pioneer in the new field of molecular biology, co-founding a world-class research laboratory and developing a technique to unlock the structures

13 Dec 2018: This approach promises to provide new insight into the acyl intermediates formed by other important enzymes. ... Nature News and Views:Primary Sidebar. Search. Search this website. 2024 MRC Laboratory of Molecular Biology,.

16 Nov 2018: This requires a complex set of machinery called the replisome to unwind the paired strands of DNA allowing different polymerase enzymes to produce new copies. ... A new study from Joseph Yeeles’ group in the LMB’s PNAC Division has shown the first

6 Jul 2018: This year as part of the annual MRC Festival of Medical Research, twenty-five scientists and support staff from across the MRC, including the LMB’s

6 Dec 2018: potential to revolutionise the discovery and synthesis of new classes of materials and pharmaceuticals. ... These experiments provide a key advance in the development of cell-based factories that use genetic information to encode the synthesis of new

16 May 2018: More recently, Melina’s lab, in collaboration with Dean Clift from Leo James’ group in the LMB’s PNAC Division, developed a new method for protein degradation – Trim-Away.

1 Jun 2018: Martin and Joe found for the first time that the yeast replisome can re-establish a new leading strand beyond the damage without the assistance of accessory factors, via the activity ... Martin and Joe then pinpointed down the source of this inefficiency

21 Jun 2018: Gel showing global poly(A) tail lengths which shorten over time. Scientists in Lori Passmore’s group in the LMB’s Structural Studies Division have revealed new mechanistic insights into the ... This work provides new insights into the interplay of

27 Apr 2018: Sjors Scheres, Group Leader in the LMB’s Structural Studies Division, has been awarded the Bijvoet Medal for his outstanding contribution to furthering

3 Oct 2018: Arnold, for developing a method known as phage display and using it for the directed evolution of antibodies, with the aim of producing new pharmaceuticals. ... Today, monoclonal antibodies account for a third of all new treatments.